Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24915510 | 0.85 | ALOX15 (0.43) | GSRBLMKMT2AALOX15CHRM2 | |
| SCHEMBL17305092 | 0.82 | CES2 (0.48) | KMT2AMEN1DPP7CYP1A2 | |
| SCHEMBL5369661 | 0.82 | ALOX15 (0.52) | CYP2D6NFKB1GSRBLMKMT2A | |
| SCHEMBL28288550 | 0.80 | CES2 (0.52) | KMT2AMEN1CYP1A2 | |
| SCHEMBL19186295 | 0.80 | CHRM2 (0.54) | CYP2D6NFKB1GSRBLMKMT2A | |
| SCHEMBL14301143 | 0.79 | DDAH1 (0.41) | KMT2AMEN1DPP7CYP1A2 | |
| SCHEMBL17029472 | 0.77 | GSR (0.59) | CYP2D6NFKB1GSRBLMKMT2A | |
| Asparagine SCHEMBL28884540 | 0.74 | GSR (0.56) | NFKB1GSRBLMKMT2AALOX15 | |
| SCHEMBL8260805 | 0.74 | DDAH1 (0.37) | BLMKMT2AALOX15MEN1ALDH1A1 | |
| Asparagine SCHEMBL28884539 | 0.74 | GSR (0.56) | NFKB1GSRBLMKMT2AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220054590-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | JANSSEN BIOTECH, INC. | 2022-02-24 | — | — | US | claimed |
| US-11083776-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2021-08-10 | — | — | US | claimed |
| US-20200054712-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2020-02-20 | — | — | US | claimed |
| US-10463714-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2019-11-05 | — | — | US | claimed |
| US-20160287666-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2016-10-06 | — | — | US | claimed |
| US-7279149-B2 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2007-10-09 | — | — | US | claimed |
| WO-2005042005-A1 | AMINO ACID COMPOSITION WITH INCREASED BLOOD BRAIN BARRIER PERMEABILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-05-12 | — | — | WO | claimed |
| US-20050095201-A1 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2005-05-05 | — | — | US | claimed |
| US-20220054590-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | JANSSEN BIOTECH, INC. | 2022-02-24 | — | — | US | disclosed |
| US-20210363204-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2021-11-25 | — | — | US | disclosed |
| US-11083776-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| EP-3277304-B1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH INC (US) | 2021-08-04 | — | — | EP | disclosed |
| US-20200054712-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2020-02-20 | — | — | US | disclosed |
| US-10463714-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| US-7279149-B2 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2007-10-09 | — | — | US | disclosed |
| US-7279149-B2 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2007-10-09 | — | — | US | disclosed |
| WO-2005042005-A1 | AMINO ACID COMPOSITION WITH INCREASED BLOOD BRAIN BARRIER PERMEABILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-05-12 | — | — | WO | disclosed |
| WO-2005042005-A1 | AMINO ACID COMPOSITION WITH INCREASED BLOOD BRAIN BARRIER PERMEABILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20050095201-A1 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2005-05-05 | — | — | US | disclosed |
| US-20050095201-A1 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2005-05-05 | — | — | US | disclosed |